Novartis AG ADR (NVS)vsVicarious Surgical Inc. (RBOT)
NVS
Novartis AG ADR
$148.38
-0.99%
HEALTHCARE · Cap: $273.77B
RBOT
Vicarious Surgical Inc.
$0.69
+3.78%
HEALTHCARE · Cap: $7.07M
Smart Verdict
WallStSmart Research — data-driven comparison
NVS leads profitability with a 23.9% profit margin vs 0.0%. NVS earns a higher WallStSmart Score of 49/100 (D+).
NVS
Hold49
out of 100
Grade: D+
RBOT
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-62.1%
Fair Value
$91.39
Current Price
$148.38
$56.99 premium
Intrinsic value data unavailable for RBOT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Reasonable price relative to book value
Areas to Watch
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Revenue declined 0.7%
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bull Case : RBOT
The strongest argument for RBOT centers on Price/Book.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, Debt/Equity, PEG Ratio.
Bear Case : RBOT
The primary concerns for RBOT are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
NVS profiles as a declining stock while RBOT is a value play — different risk/reward profiles.
RBOT carries more volatility with a beta of 1.82 — expect wider price swings.
RBOT is growing revenue faster at 0.0% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (49/100 vs 23/100), backed by strong 23.9% margins. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Vicarious Surgical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Vicarious Surgical Inc. (RBOT) is an innovative medical technology firm that is transforming surgical procedures through its state-of-the-art robotic surgical systems. By harnessing a proprietary platform that combines advanced robotics and artificial intelligence, Vicarious Surgical pioneers minimally invasive surgery, enhancing surgeons' precision, control, and visualization. The company's commitment to improving surgical efficiency and reducing patient recovery times positions it as a key player in the expanding surgical robotics market, addressing the growing demand for effective robotic-assisted interventions in modern healthcare. With a strong focus on innovation, Vicarious Surgical is dedicated to advancing patient care and outcomes in a rapidly evolving medical landscape.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?